3 chapters across the catalog
During the late 1980s, the slow pace of FDA drug approvals led to the creation of "buyers clubs" for experimental treatments. Dr. Fauci admitted in 1988 that if he were a patient, he would seek drugs "on the street," a statement the hosts find remarkable given modern medical mandates.
Future medical practices may involve adjusting vaccine dosages based on a person's genetic profile rather than race. Suggestions include giving African Americans half-doses of certain vaccines if their immune response is naturally stronger. Critics argue that using Black populations to establish baselines for "personalized" medicine before rolling it out to wealthier demographics is ethically problematic.
Shaving Vaccine Development Timelines and Testing in Vulnerable Communities
The typical 3-to-12-year timeline for vaccine development was significantly shortened for COVID-19 through government pre-financing. Concerns are raised about testing these new technologies on vulnerable populations in Africa and urban American centers. Historical precedents like the Tuskegee experiment are cited as reasons for deep-seated apprehension regarding rapid medical rollouts.
